Key Takeaways
- • Basalt Health raised a $20 million Series A led by returning investor NEA, with participation from existing investors Frist Cressey Ventures and 25m Health, bringing total capital raised to approximately $24.5 million.
- • The company's AI platform cut median referral processing time by 86% at Lifepoint Health, from 8.5 minutes to 1.2 minutes.
- • Basalt plans to use the new capital to expand its product and scale across 111 markets, including 62 ScionHealth hospitals and 49 Lifepoint Health markets, by the end of 2026.
- • The platform targets post-acute care placement, a process that the company says sends case managers faxing lengthy clinical packets to an average of 6.6 facilities per placement and contributes to an estimated $17 billion in avoidable readmission costs annually.
Summary
Basalt Health, a Nashville, Tenn.-based company whose AI platform helps patients transition to post-acute care faster, announced a $20 million Series A financing led by returning investor NEA, according to a Business Wire release. Existing investors Frist Cressey Ventures and 25m Health also participated. The round brings the company's total capital raised to approximately $24.5 million. Publications covering the round, including Axios Pro, describe Basalt as a provider of post-acute care software and report that CEO Ben Hackett confirmed the financing.
The company is targeting a placement process that its founders describe as outdated. According to the company, roughly 14 million patients enter post-acute care each year, and case managers typically fax lengthy clinical packets to 6.6 facilities per placement while waiting for beds to respond. Basalt estimates that these delays and mismatches contribute to approximately $17 billion in avoidable readmission costs annually. Hackett described the problem in direct terms: "Case managers are still sending 70-page packets and waiting for responses, while patients remain stranded in hospital beds."
Basalt's platform is already in use at Lifepoint Health, a diversified healthcare delivery network. The company reports that the platform reduces median referral processing time by 86%, from 8.5 minutes to 1.2 minutes. Basalt says the new capital will fund product expansion and support scaling across 111 markets, comprising 62 ScionHealth hospitals and 49 Lifepoint Health markets, by the end of 2026. Hackett, who has said his mother and grandmother were nurses, framed the funding as a means to "transform one of healthcare's most stubbornly inefficient systems." The company's stated figures are drawn from its own announcement and have not been independently verified.
The company is targeting a placement process that its founders describe as outdated. According to the company, roughly 14 million patients enter post-acute care each year, and case managers typically fax lengthy clinical packets to 6.6 facilities per placement while waiting for beds to respond. Basalt estimates that these delays and mismatches contribute to approximately $17 billion in avoidable readmission costs annually. Hackett described the problem in direct terms: "Case managers are still sending 70-page packets and waiting for responses, while patients remain stranded in hospital beds."
Basalt's platform is already in use at Lifepoint Health, a diversified healthcare delivery network. The company reports that the platform reduces median referral processing time by 86%, from 8.5 minutes to 1.2 minutes. Basalt says the new capital will fund product expansion and support scaling across 111 markets, comprising 62 ScionHealth hospitals and 49 Lifepoint Health markets, by the end of 2026. Hackett, who has said his mother and grandmother were nurses, framed the funding as a means to "transform one of healthcare's most stubbornly inefficient systems." The company's stated figures are drawn from its own announcement and have not been independently verified.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.